• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD49d 是小鼠中一种新型的髓系来源的抑制性细胞亚群的标志物。

CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.

机构信息

Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Germany.

出版信息

J Immunol. 2010 Jul 1;185(1):203-10. doi: 10.4049/jimmunol.0903573. Epub 2010 Jun 4.

DOI:10.4049/jimmunol.0903573
PMID:20525890
Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogenous population of cells that negatively regulate the immune response during tumor progression, inflammation, and infection. In this study, through gene-expression analysis, we have identified a new marker, CD49d, which is expressed exclusively on CD11b(+)Gr-1(dull/int.) MDSCs. We have characterized two subpopulations of MDSCs based on CD49d expression in two different settings, a mouse model of inflammatory bowel disease and tumor-bearing mice. The CD49d(+) subset of MDSCs was mainly monocytic and strongly suppressed Ag-specific T cell proliferation in an NO-dependent mechanism similar to Gr-1(dull/int.) MDSCs. Alternatively, CD49d(-) cells were granulocytic and poorly inhibited T cell proliferation compared with CD11b(+)Gr-1(high) cells. Both mouse models showed preferential expansion of the granulocytic CD49d(-) subset. We suggest that CD49d can be used as an alternative marker for Gr-1 to differentiate between the subpopulations of MDSCs together with CD11b, which will ultimately help in understanding the mechanisms of immune suppression by MDSCs.

摘要

髓系来源的抑制细胞(MDSCs)是一种异质性细胞群体,在肿瘤进展、炎症和感染过程中负向调节免疫反应。在这项研究中,我们通过基因表达分析,鉴定了一个新的标志物 CD49d,它仅在 CD11b(+)Gr-1(dull/int.) MDSCs 上表达。我们根据 CD49d 的表达,在两种不同的情况下,即炎症性肠病小鼠模型和荷瘤小鼠中,对 MDSCs 的两个亚群进行了特征描述。CD49d(+) MDSC 亚群主要为单核细胞,以类似于 Gr-1(dull/int.) MDSCs 的 NO 依赖性机制强烈抑制 Ag 特异性 T 细胞增殖。相比之下,CD49d(-)细胞与 CD11b(+)Gr-1(high)细胞相比,对 T 细胞增殖的抑制作用较差。两种小鼠模型均显示出粒细胞性 CD49d(-)亚群的优先扩增。我们认为,CD49d 可以与 CD11b 一起作为 Gr-1 的替代标志物,用于区分 MDSCs 的亚群,这将有助于最终理解 MDSCs 免疫抑制的机制。

相似文献

1
CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.CD49d 是小鼠中一种新型的髓系来源的抑制性细胞亚群的标志物。
J Immunol. 2010 Jul 1;185(1):203-10. doi: 10.4049/jimmunol.0903573. Epub 2010 Jun 4.
2
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.炎症性肠病中的髓源性抑制细胞:一种新的免疫调节途径。
Gastroenterology. 2008 Sep;135(3):871-81, 881.e1-5. doi: 10.1053/j.gastro.2008.06.032. Epub 2008 Jun 12.
3
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.GM-CSF 决定髓源性抑制细胞亚群的免疫抑制强度的等级。
Eur J Immunol. 2010 Jan;40(1):22-35. doi: 10.1002/eji.200939903.
4
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.小鼠卵巢癌相关Gr-1+CD11b+髓样细胞免疫抑制中的CD80
Cancer Res. 2006 Jul 1;66(13):6807-15. doi: 10.1158/0008-5472.CAN-05-3755.
5
Myeloid-derived suppressor cell heterogeneity and subset definition.髓系来源抑制性细胞异质性及其亚群定义。
Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17.
6
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.肿瘤浸润性单核细胞髓系来源抑制细胞介导 CCR5 依赖性募集调节性 T 细胞有利于肿瘤生长。
J Immunol. 2012 Dec 15;189(12):5602-11. doi: 10.4049/jimmunol.1201018. Epub 2012 Nov 14.
7
Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.通过联合脂多糖和γ干扰素处理激活髓源性抑制细胞会损害树突状细胞的发育。
Eur J Immunol. 2009 Oct;39(10):2865-76. doi: 10.1002/eji.200939486.
8
Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection.髓源性抑制细胞在急性克氏锥虫感染时浸润心脏。
J Immunol. 2011 Sep 1;187(5):2656-65. doi: 10.4049/jimmunol.1002928. Epub 2011 Jul 29.
9
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.肿瘤诱导的髓系来源抑制性细胞亚群对不同的 CD8+T 细胞激活事件发挥抑制或刺激作用。
Eur J Immunol. 2013 Nov;43(11):2930-42. doi: 10.1002/eji.201343349. Epub 2013 Aug 25.
10
Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.髓系来源的抑制细胞在肿瘤和器官的浸润。
Int Immunopharmacol. 2011 Jul;11(7):816-26. doi: 10.1016/j.intimp.2011.02.021. Epub 2011 Mar 2.

引用本文的文献

1
Mathematical model of tumor-macrophage dynamics in glioma to advance myeloid-targeted therapies.胶质瘤中肿瘤-巨噬细胞动力学的数学模型以推进髓系靶向治疗
bioRxiv. 2025 Jul 18:2025.07.14.664717. doi: 10.1101/2025.07.14.664717.
2
Unraveling the Complexities of Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease.解析炎症性肠病中髓源性抑制细胞的复杂性
Int J Mol Sci. 2025 Apr 2;26(7):3291. doi: 10.3390/ijms26073291.
3
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
髓源性抑制细胞:结直肠癌中关键的免疫抑制调节因子和治疗靶点(综述)。
Int J Oncol. 2024 Sep;65(3). doi: 10.3892/ijo.2024.5673. Epub 2024 Jul 26.
4
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.了解胶质瘤的免疫抑制微环境:机制见解和临床观点。
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7.
5
Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies.胶质母细胞瘤免疫治疗的放射基因组学生物标志物:磁共振成像研究的系统评价
Neurooncol Adv. 2024 Apr 5;6(1):vdae055. doi: 10.1093/noajnl/vdae055. eCollection 2024 Jan-Dec.
6
Myeloid-derived suppressor cells in cancer and cancer therapy.髓源性抑制细胞在癌症和癌症治疗中的作用。
Nat Rev Clin Oncol. 2024 Feb;21(2):147-164. doi: 10.1038/s41571-023-00846-y. Epub 2024 Jan 8.
7
The recent progress of myeloid-derived suppressor cell and its targeted therapies in cancers.髓源性抑制细胞及其在癌症中的靶向治疗的最新进展
MedComm (2020). 2023 Aug 2;4(4):e323. doi: 10.1002/mco2.323. eCollection 2023 Aug.
8
Myeloid-derived suppressor cells and pulmonary hypertension.髓系来源的抑制细胞与肺动脉高压。
Front Immunol. 2023 Jun 7;14:1189195. doi: 10.3389/fimmu.2023.1189195. eCollection 2023.
9
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.髓系来源的抑制细胞:抗肿瘤免疫治疗的一个新靶点。
Mol Cancer. 2022 Sep 26;21(1):184. doi: 10.1186/s12943-022-01657-y.
10
VLA-1 Binding to Collagen IV Controls Effector T Cell Suppression by Myeloid-Derived Suppressor Cells in the Splenic Red Pulp.VLA-1 与胶原 IV 的结合控制着骨髓来源的抑制细胞在脾红髓中对效应 T 细胞的抑制作用。
Front Immunol. 2021 Jan 18;11:616531. doi: 10.3389/fimmu.2020.616531. eCollection 2020.